172 related articles for article (PubMed ID: 17265125)
1. Elevated expression of autocrine motility factor receptor correlates with overexpression of RhoC and indicates poor prognosis in hepatocellular carcinoma.
Wang W; Yang LY; Yang ZL; Peng JX; Yang JQ
Dig Dis Sci; 2007 Mar; 52(3):770-5. PubMed ID: 17265125
[TBL] [Abstract][Full Text] [Related]
2. Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis.
Wang W; Yang LY; Huang GW; Lu WQ; Yang ZL; Yang JQ; Liu HL
Br J Cancer; 2004 Jun; 90(12):2349-55. PubMed ID: 15150600
[TBL] [Abstract][Full Text] [Related]
3. [Overexpression of the RhoC gene correlates with invasion and metastasis of hepatocellular carcinoma].
Wang W; Yang LY; Huang GW; Yang ZL; Lu WQ; Peng JX; Yang JQ
Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):279-82. PubMed ID: 15312362
[TBL] [Abstract][Full Text] [Related]
4. Expression and significance of RhoC gene in hepatocellular carcinoma.
Wang W; Yang LY; Yang ZL; Huang GW; Lu WQ
World J Gastroenterol; 2003 Sep; 9(9):1950-3. PubMed ID: 12970882
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of cell motility activation factors in patients with tongue squamous cell carcinoma.
Endo K; Shirai A; Furukawa M; Yoshizaki T
Hum Pathol; 2006 Aug; 37(8):1111-6. PubMed ID: 16867875
[TBL] [Abstract][Full Text] [Related]
6. YMO1 suppresses invasion and metastasis by inhibiting RhoC signaling and predicts favorable prognosis in hepatocellular carcinoma.
Chang RM; Pei L; Fang F; Xu JF; Yang H; Zuo CH; Zhou JH; Luo GQ; Yang LY
Oncotarget; 2016 Aug; 7(34):55585-55600. PubMed ID: 27487132
[TBL] [Abstract][Full Text] [Related]
7. Autocrine motility factor receptor signaling pathway promotes cell invasion via activation of ROCK-2 in esophageal squamous cell cancer cells.
Wang L; Hou G; Xue L; Li J; Wei P; Xu P
Cancer Invest; 2010 Dec; 28(10):993-1003. PubMed ID: 20504226
[TBL] [Abstract][Full Text] [Related]
8. Autocrine motility factor receptor: a clinical review.
Chiu CG; St-Pierre P; Nabi IR; Wiseman SM
Expert Rev Anticancer Ther; 2008 Feb; 8(2):207-17. PubMed ID: 18279062
[TBL] [Abstract][Full Text] [Related]
9. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of the autocrine motility factor receptor correlates with poor prognosis and promotes metastasis in gastric carcinoma.
Huang Z; Zhang N; Zha L; Mao HC; Chen X; Xiang JF; Zhang H; Wang ZW
Asian Pac J Cancer Prev; 2014; 15(2):989-97. PubMed ID: 24568530
[TBL] [Abstract][Full Text] [Related]
11. Correlation between loss of E-cadherin expression and overexpression of autocrine motility factor receptor in association with progression of human gastric cancers.
Kawanishi K; Doki Y; Shiozaki H; Yano M; Inoue M; Fukuchi N; Utsunomiya T; Watanabe H; Monden M
Am J Clin Pathol; 2000 Feb; 113(2):266-74. PubMed ID: 10664629
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of invasion and metastasis of hepatocellular carcinoma cells via targeting RhoC in vitro and in vivo.
Wang W; Wu F; Fang F; Tao Y; Yang L
Clin Cancer Res; 2008 Nov; 14(21):6804-12. PubMed ID: 18980974
[TBL] [Abstract][Full Text] [Related]
13. [Expression of RhoC protein in human primary hepatocellular carcinoma and its clinical significance].
Cai XJ; Xu GG; Shen B
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 35(4):394-6. PubMed ID: 16924703
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Pin1 and rho signaling partners correlates with metastatic behavior and poor recurrence-free survival of hepatocellular carcinoma patients.
Ng L; Kwan V; Chow A; Yau TC; Poon RT; Pang R; Law WL
BMC Cancer; 2019 Jul; 19(1):713. PubMed ID: 31324164
[TBL] [Abstract][Full Text] [Related]
15. Autocrine motility factor receptor expression implies an unfavourable prognosis in resected stage I pulmonary adenocarcinomas.
Kaynak K; Kara M; Oz B; Akgoz B; Sar M; Raz A
Acta Chir Belg; 2005 Aug; 105(4):378-82. PubMed ID: 16184720
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of RhoA is associated with poor prognosis in hepatocellular carcinoma.
Li XR; Ji F; Ouyang J; Wu W; Qian LY; Yang KY
Eur J Surg Oncol; 2006 Dec; 32(10):1130-4. PubMed ID: 16806792
[TBL] [Abstract][Full Text] [Related]
17. Expression of autocrine motility factor (AMF) and its receptor, AMFR, in human breast cancer.
Jiang WG; Raz A; Douglas-Jones A; Mansel RE
J Histochem Cytochem; 2006 Feb; 54(2):231-41. PubMed ID: 16204225
[TBL] [Abstract][Full Text] [Related]
18. BTB/POZ domain-containing protein 7: epithelial-mesenchymal transition promoter and prognostic biomarker of hepatocellular carcinoma.
Tao YM; Huang JL; Zeng S; Zhang S; Fan XG; Wang ZM; Yang HX; Yuan XH; Wang P; Wu F; Luo J; Zeng DY; Shen H
Hepatology; 2013 Jun; 57(6):2326-37. PubMed ID: 23325674
[TBL] [Abstract][Full Text] [Related]
19. Neuregulin/erythroblastic leukemia viral oncogene homolog 3 autocrine loop contributes to invasion and early recurrence of human hepatoma.
Hsieh SY; He JR; Hsu CY; Chen WJ; Bera R; Lin KY; Shih TC; Yu MC; Lin YJ; Chang CJ; Weng WH; Huang SF
Hepatology; 2011 Feb; 53(2):504-16. PubMed ID: 21246584
[TBL] [Abstract][Full Text] [Related]
20. Fbxw7 regulates hepatocellular carcinoma migration and invasion via Notch1 signaling pathway.
Wang X; Zhang J; Zhou L; Sun W; Zheng ZG; Lu P; Gao Y; Yang XS; Zhang ZC; Tao KS; Dou KF
Int J Oncol; 2015 Jul; 47(1):231-43. PubMed ID: 25955618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
